Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
Lisa Jerome, Allison A. Feduccia, Julie B. Wang, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Michael C. Mithoefer, Rick Doblin
Psychopharmacology (Berl) November 1, 2024 DOI: 10.1007/s00213-024-06665-y via PubMed Central
Summary
AI-generated from the abstractThis is a retraction note for a previously published article on the long-term outcomes of MDMA-assisted psychotherapy for PTSD. The original article reported a longitudinal pooled analysis of six phase 2 trials, but it has been retracted. The retraction does not provide any findings or data about the treatment's efficacy or long-term effects.
Study at a glance
| Characteristics | Longitudinal pooled analysis Peer reviewed |
|---|---|
| Intervention | MDMA-assisted psychotherapy |
| Duration | 12-month follow-up |
| Keywords | Therapeutic method Innovative approach PTSD Symptom Relief PTSD Recovery Lasting benefits |
| Citations | 10 |
| Key finding | MDMA-assisted psychotherapy produced sustained improvements in PTSD symptoms over 12 months of follow-up. |
Abstract
Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.